WATERLOO, Belgium--(BUSINESS WIRE)--Advanced Medical Diagnostics SA/NV (AMD), a privately held company that has developed HistoScanning™, today outlined its activities at the European Association of Urology Meeting (EAU) that is taking place in Vienna from the 18th to the 22nd March. HistoScanning™ is a Tissue Characterisation modality based on raw ultrasound data. HistoScanning™ provides additional and meaningful information for better management of cancer patients by providing visual reassurance for decision making.
